We are live on ! Find out more
TAM

Tocqueville Asset Management Portfolio holdings

AUM $7.56B
1-Year Est. Return 44.87%
This Fund
S&P 500
This Quarter Est. Return
+10.28%
1 Year Est. Return
+44.87%
3 Year Est. Return
+121.98%
5 Year Est. Return
+153.06%
10 Year Est. Return
+501.33%
AUM
$7.27B
AUM Growth
+$520M
Cap. Flow
-$125M
Cap. Flow %
-1.72%
Top 10 Hldgs %
25.44%
Holding
784
New
56
Increased
191
Reduced
310
Closed
46

Sector Composition

Rank Sector Weight
1 Technology 17.89%
2 Consumer Discretionary 16.35%
3 Miscellaneous 12.25%
4 Industrials 10.47%
5 Healthcare 9.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ADEA icon
626
Adeia
ADEA
$2.89B
$214K ﹤0.01%
+42,774
New +$213K
BFAM icon
627
Bright Horizons
BFAM
$3.61B
$214K ﹤0.01%
1,700
-1,800
-51% -$250K
JNPR
628
DELISTED
Juniper Networks
JNPR
$214K ﹤0.01%
+6,000
New +$188K
SWAV
629
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
$214K ﹤0.01%
+1,200
New +$237K
MOV icon
630
Movado Group
MOV
$766M
$213K ﹤0.01%
+5,092
New +$192K
MKL icon
631
Markel Group
MKL
$22.4B
$210K ﹤0.01%
170
MNA icon
632
IQ ARB Merger Arbitrage ETF
MNA
$254M
$210K ﹤0.01%
6,515
RDS.A
633
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$210K ﹤0.01%
4,843
EWJ icon
634
iShares MSCI Japan ETF
EWJ
$22.6B
$209K ﹤0.01%
3,125
CIO
635
DELISTED
City Office REIT
CIO
$198K ﹤0.01%
+10,024
New +$184K
SEEL
636
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
$193K ﹤0.01%
31
-1
-3% -$7.68K
CEF icon
637
Sprott Physical Gold and Silver Trust
CEF
$8.31B
$179K ﹤0.01%
10,100
MQ icon
638
Marqeta
MQ
$1.69B
$172K ﹤0.01%
+2,500
New +$224K
NBSE
639
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
$150K ﹤0.01%
2,675
-1,025
-28% -$68.8K
SGMO
640
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$147K ﹤0.01%
19,580
-5,000
-20% -$43.4K
MDNA
641
DELISTED
Medicenna Therapeutics Corp. Common Shares
MDNA
$143K ﹤0.01%
88,000
-5,000
-5% -$10.4K
III icon
642
Information Services Group
III
$246M
$130K ﹤0.01%
+17,089
New +$138K
ACXP icon
643
Acurx Pharmaceuticals
ACXP
$6.1M
$108K ﹤0.01%
1,255
+300
+31% +$28.5K
CPRX
644
DELISTED
Catalyst Pharmaceutical
CPRX
$106K ﹤0.01%
15,594
-44
-0.3% -$289
ATYR
645
aTyr Pharma
ATYR
$54.3M
$91K ﹤0.01%
12,150
-2,700
-18% -$22.5K
POTX
646
DELISTED
Global X Cannabis ETF
POTX
$90K ﹤0.01%
2,592
+292
+13% +$13.8K
SEI
647
Solaris Energy Infrastructure
SEI
$3.51B
$79K ﹤0.01%
12,050
-1,700
-12% -$12.6K
ONCS
648
DELISTED
OncoSec Medical Incorporated
ONCS
$72K ﹤0.01%
3,432
+1,182
+53% +$40K
NMTR
649
DELISTED
9 Meters Biopharma
NMTR
$10K ﹤0.01%
+510
New +$11.4K
ALLE icon
650
Allegion
ALLE
$13.6B
-1,666
Closed -$220K

Similar funds

Tocqueville Asset Management's Q4 2021 Portfolio in Review

As of Q4 2021, Tocqueville Asset Management held 784 positions worth $7.27B, up 7.7% from $6.75B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Tocqueville Asset Management's Q4 2021 filing shows 56 new, 191 increased, 310 reduced and 46 closed positions. Its largest new stake was Clarivate: 381,190 shares worth $8.97M. The largest sale was Lockheed Martin, an estimated $14.3M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Miscellaneous.

  • Tocqueville Asset Management's largest Q4 2021 buy was Clarivate: 381,190 shares worth $8.97M.
  • Tocqueville Asset Management added most to Qualcomm in Q4 2021, an estimated $9.85M increase.
  • Tocqueville Asset Management's biggest Q4 2021 reduction was Lockheed Martin, cutting an estimated $14.3M.
  • Tocqueville Asset Management fully exited Avangrid, Inc. in Q4 2021, selling an estimated $4.66M.
  • Tocqueville Asset Management's ten largest holdings make up 25% of its $7.27B portfolio in Q4 2021.
  • Tocqueville Asset Management opened 56 new positions and closed 46 in Q4 2021.
  • Tocqueville Asset Management's portfolio value rose 7.7% quarter-over-quarter to $7.27B.

Based on Tocqueville Asset Management's 13F filing for Q4 2021, filed 14 Feb 2022.